Remove 2012 Remove COVID-19 Remove Regulatory Compliance
article thumbnail

FDA Guidance Provides Relief for MDR Reporting During a Pandemic

Exeed Regulatory Compliance

FDA has just revised its relatively less known 2012 guidance entitled “Post-market Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic” to clarify that the guidance is applicable to any pandemic, not just an influenza pandemic.

FDA 52